Skip Nav Destination
Issues
Cancer Research
Table of Contents
Perspectives in Cancer Research
Advances in Brief
Evaluation of Fanconi Anemia Genes in Familial Breast Cancer Predisposition
Sheila Seal; Rita Barfoot; Hiran Jayatilake; Paula Smith; Anthony Renwick; Linda Bascombe; Lesley McGuffog; D. Gareth Evans; Diana Eccles; The Breast Cancer Susceptibility Collaboration (UK); Douglas F. Easton; Michael R. Stratton; Nazneen Rahman
Molecular Biology, Pathobiology, and Genetics
Epigenetic Inactivation of CHFR and Sensitivity to Microtubule Inhibitors in Gastric Cancer
Ayumi Satoh; Minoru Toyota; Fumio Itoh; Yasushi Sasaki; Hiromu Suzuki; Kazuhiro Ogi; Takefumi Kikuchi; Hiroaki Mita; Toshiharu Yamashita; Takashi Kojima; Masanobu Kusano; Masahiro Fujita; Masao Hosokawa; Takao Endo; Takashi Tokino; Kohzoh Imai
Highly Expressed Genes in Pancreatic Ductal Adenocarcinomas: A Comprehensive Characterization and Comparison of the Transcription Profiles Obtained from Three Major Technologies
Christine A. Iacobuzio-Donahue; Raheela Ashfaq; Anirban Maitra; N. Volkan Adsay; Grace L. Shen-Ong; Karin Berg; Michael A. Hollingsworth; John L. Cameron; Charles J. Yeo; Scott E. Kern; Michael Goggins; Ralph H. Hruban
Identification of Clinically Relevant Genes on Chromosome 11 in a Functional Model of Ovarian Cancer Tumor Suppression
Euan A. Stronach; Grant C. Sellar; Cherie Blenkiron; Genevieve J. Rabiasz; Karen J. Taylor; Eric P. Miller; Charles E. Massie; Awatif Al-Nafussi; John F. Smyth; David J. Porteous; Hani Gabra
Cell and Tumor Biology
High Heparanase Activity in Multiple Myeloma Is Associated with Elevated Microvessel Density
Thomas Kelly; Hua-Quan Miao; Yang Yang; Elizabeth Navarro; Paul Kussie; Yan Huang; Veronica MacLeod; Jonathan Casciano; Lija Joseph; Fenghuang Zhan; Maurizio Zangari; Bart Barlogie; John Shaughnessy; Ralph D. Sanderson
Cyclophosphamide Treatment Modifies Tumor Oxygenation and Glycolytic Rates of RIF-1 Tumors: 13C Magnetic Resonance Spectroscopy, Eppendorf Electrode, and Redox Scanning
Harish Poptani; Navin Bansal; Walter T. Jenkins; Dana Blessington; Anthony Mancuso; David S. Nelson; Michael Feldman; Edward J. Delikatny; Britton Chance; Jerry D. Glickson
Migration-Stimulating Factor: A Genetically Truncated Onco-Fetal Fibronectin Isoform Expressed by Carcinoma and Tumor-Associated Stromal Cells
Seth L. Schor; Ian R. Ellis; Sarah J. Jones; Robin Baillie; Kanjula Seneviratne; Julia Clausen; Katsumi Motegi; Borek Vojtesek; Katerina Kankova; Elizabeth Furrie; Mark J. Sales; Ana M. Schor; Richard A. Kay
Patterns of Chromosomal Imbalances Defines Subgroups of Breast Cancer with Distinct Clinical Features and Prognosis. A Study of 305 Tumors by Comparative Genomic Hybridization
Karin Rennstam; Minna Ahlstedt-Soini; Bo Baldetorp; Pär-Ola Bendahl; Åke Borg; Ritva Karhu; Minna Tanner; Mika Tirkkonen; Jorma Isola
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Cephalostatin 1 Selectively Triggers the Release of Smac/DIABLO and Subsequent Apoptosis That Is Characterized by an Increased Density of the Mitochondrial Matrix
Verena M. Dirsch; Irina M. Müller; Sören T. Eichhorst; George R. Pettit; Yoshiaki Kamano; Masuo Inoue; Jun-Ping Xu; Yoshitatsu Ichihara; Gerhard Wanner; Angelika M. Vollmar
Combined Therapy with Direct and Indirect Angiogenesis Inhibition Results in Enhanced Antiangiogenic and Antitumor Effects
Amir Abdollahi; Kenneth E. Lipson; Axel Sckell; Heike Zieher; Frank Klenke; Daniel Poerschke; Alexandra Roth; Xiaohong Han; Martin Krix; Marc Bischof; Philip Hahnfeldt; Hermann-Josef Grone; Juergen Debus; Lynn Hlatky; Peter E. Huber
A Fully Human Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor Blocks Ligand-Dependent Signaling and Inhibits Human Tumor Growth in Vivo
Douglas Burtrum; Zhenping Zhu; Dan Lu; Donna Marie Anderson; Marie Prewett; Daniel S. Pereira; Rajiv Bassi; Rashed Abdullah; Andrea T. Hooper; Henry Koo; Xenia Jimenez; Danielle Johnson; Robin Apblett; Paul Kussie; Peter Bohlen; Larry Witte; Daniel J. Hicklin; Dale L. Ludwig
Induction of PIG3 and NOXA through Acetylation of p53 at 320 and 373 Lysine Residues as a Mechanism for Apoptotic Cell Death by Histone Deacetylase Inhibitors
Takeshi Terui; Ken Murakami; Rishu Takimoto; Minoru Takahashi; Koichi Takada; Tsuzuku Murakami; Shinya Minami; Takuya Matsunaga; Tetsuji Takayama; Junji Kato; Yoshiro Niitsu
Intratumoral Immunization with Tumor RNA-Pulsed Dendritic Cells Confers Antitumor Immunity in a C57BL/6 Pancreatic Murine Tumor Model
Tanja Schmidt; Carsten Ziske; Angela Märten; Stefan Endres; Klaus Tiemann; Volker Schmitz; Marcus Gorschlüter; Christof Schneider; Tilman Sauerbruch; Ingo G. H. Schmidt-Wolf
Repression of Vascular Endothelial Growth Factor A in Glioblastoma Cells Using Engineered Zinc Finger Transcription Factors
Andrew W. Snowden; Lei Zhang; Fyodor Urnov; Carolyn Dent; Yann Jouvenot; Xiaohong Zhong; Edward J. Rebar; Andrew C. Jamieson; H. Steven Zhang; Siyuan Tan; Casey C. Case; Carl O. Pabo; Alan P. Wolffe; Philip D. Gregory
Geldanamycin and 17-Allylamino-17-demethoxygeldanamycin Potentiate the in Vitro and in Vivo Radiation Response of Cervical Tumor Cells via the Heat Shock Protein 90-Mediated Intracellular Signaling and Cytotoxicity
Kheem S. Bisht; C. Matthew Bradbury; David Mattson; Aradhana Kaushal; Anastasia Sowers; Stephanie Markovina; Karen L. Ortiz; Leah K. Sieck; Jennifer S. Isaacs; Martin W. Brechbiel; James B. Mitchell; Leonard M. Neckers; David Gius
Immunology
Extra-Lymphatic Solid Tumor Growth Is Not Immunologically Ignored and Results in Early Induction of Antigen-Specific T-Cell Anergy: Dominant Role of Cross-Tolerance to Tumor Antigens
Alex Cuenca; Fengdong Cheng; Hongwei Wang; Jason Brayer; Pedro Horna; Lingping Gu; Harold Bien; Ivan M. Borrello; Hyam I. Levitsky; Eduardo M. Sotomayor
Clinical Research
Letter to the Editor
Acknowledgement to Reviewers
Journal Archive
Cancer Research
(1941-Present; volumes 1-current)Published twice monthly since 1987. From 1941-1986, published monthly.
(ISSN 0008-5472)
The American Journal of Cancer
(1931-1940; volumes 15-40)Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.
(ISSN 0099-7374)
The Journal of Cancer Research
(1916-1930); volumes 1-14)Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.
(ISSN 0099-7013)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.
RSS Feeds